BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6193975)

  • 1. Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasia.
    Stahl F; Schnorr D; Rohde W; Poppe I; Geier T; Dörner G
    Exp Clin Endocrinol; 1983 Jul; 82(1):21-8. PubMed ID: 6193975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of pituitary and testicular hormones of fertile and infertile men.
    Stanwell-Smith R; Thompson SG; Haines AP; Jeffcoate SL; Hendry WF
    Clin Reprod Fertil; 1985 Mar; 3(1):37-48. PubMed ID: 3919915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
    Cailleux-Bounacer A; Rohmer V; Lahlou N; Lefebvre H; Roger M; Kuhn JM
    Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens in seminal plasma: markers of the surface epithelium of the male reproductive tract.
    Zalata A; Hafez T; Verdonck L; Vermeulen L; Comhaire F
    Int J Androl; 1995 Oct; 18(5):271-7. PubMed ID: 8567098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating pituitary-gonadal hormones in clomiphene-induced cycles.
    Dawood MY; Saxena BB
    Obstet Gynecol; 1978 Oct; 52(4):445-50. PubMed ID: 714327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ; Dahl KD; Bremner WJ
    J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
    Bartsch G; Oberholzer M; Rohr HP
    Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
    Katayama T; Umeda K; Kazama T
    Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal disturbances in men with a prostatic adenoma (author's transl)].
    Baranowska B; Zgliczynski S; Szymanowski J
    J Urol (Paris); 1980; 86(7):551-8. PubMed ID: 6161196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine parameters in acne vulgaris.
    Schmidt JB; Lindmaier A; Spona J
    Endocrinol Exp; 1990 Dec; 24(4):457-64. PubMed ID: 2151388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone infusion on plasma levels of LH, FSH, and in addition TSH and prolactin in males, before and after oestrogen or anti-oestrogen treatment.
    van Bergeijk L; Gooren LJ; van Kessel H; Sassen AM
    Horm Metab Res; 1986 Sep; 18(9):611-5. PubMed ID: 3096859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
    Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
    Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reference values of FSH, LH, total testosterone, free testosterone, 17-beta-estradiol and SHBG in healthy children in Zaragoza].
    Cortés Blanco A; Ferrández Longás A; Mayayo Dehesa E; Labarta Aizpún JI
    An Esp Pediatr; 1999 Aug; 51(2):159-66. PubMed ID: 10495503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy: influence on serum and urinary androgen levels.
    Olsson M; Ekström L; Schulze J; Kjellman A; Akre O; Rane A; Gustafsson O
    Prostate; 2010 Feb; 70(2):200-5. PubMed ID: 19760638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.